share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Mandadi Tilak

CVS Health | 4: Statement of changes in beneficial ownership of securities

西维斯健康 | 4：持股变动声明
SEC announcement ·  04/03 16:55
Moomoo AI 已提取核心信息
On April 1, 2024, CVS Health EVP and Chief Technology Officer, Mandadi Tilak, was granted 16,339 shares of common stock (RSU) as part of a transaction with the company. The grant, which was completed on the same day, was issued at no cost to the recipient. Following this transaction, Tilak's direct holdings in CVS Health increased to a total of 82,904 shares of common stock. This event reflects the company's ongoing incentive plans for its executive leadership.
On April 1, 2024, CVS Health EVP and Chief Technology Officer, Mandadi Tilak, was granted 16,339 shares of common stock (RSU) as part of a transaction with the company. The grant, which was completed on the same day, was issued at no cost to the recipient. Following this transaction, Tilak's direct holdings in CVS Health increased to a total of 82,904 shares of common stock. This event reflects the company's ongoing incentive plans for its executive leadership.
2024年4月1日，作为与该公司交易的一部分，CVS Health执行副总裁兼首席技术官曼达迪·蒂拉克获得了16,339股普通股（RSU）。这笔补助金于当天完成，免费发放给接受者。在这笔交易之后，蒂拉克在CVS Health的直接持股量增加到总共82,904股普通股。该活动反映了公司对执行领导层的持续激励计划。
2024年4月1日，作为与该公司交易的一部分，CVS Health执行副总裁兼首席技术官曼达迪·蒂拉克获得了16,339股普通股（RSU）。这笔补助金于当天完成，免费发放给接受者。在这笔交易之后，蒂拉克在CVS Health的直接持股量增加到总共82,904股普通股。该活动反映了公司对执行领导层的持续激励计划。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息